CRISPR-based in situ engineering tumor cells to reprogram macrophages for effective cancer immunotherapy

Meng Lin,Zhenzhen Yang, Yiliang Yang,Yiwei Peng,Jiajia Li,Yitian Du,Qi Sun,Datong Gao,Quan Yuan,Yu Zhou,Xinyi Chen,Xianrong Qi

Nano Today（2022）

引用 24|浏览19

暂无评分

摘要

•A selective responsiveness accelerated gene delivery system was constructed.•The gene delivery system rendered tumor-specific CD47 knockout and engineered tumor cells into factories of IL-12.•Combination of CD47 blockade and IL-12 production synergistically promoted the macrophage-mediated immunotherapy.

查看译文

关键词

CD47 blockade,IL-12 production,Selective responsiveness accelerated gene delivery system,TAM polarization,CRISPR/Cas9

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要